Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer

Shuiliang Wang(Xiamen University), Bolin Liu(The University of Texas MD Anderson Cancer Center)
Breast Cancer Research
October 29, 2013
Cited by 56


Related Papers